ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Sep 19, 2014
Insider Transaction Report
Form 4
BRISTOW MICHAEL R
DirectorChief Science and Med. Officer
Transactions
- Sale
Common Stock
2014-09-18$1.30/sh−13,853$18,009→ 292,625 total
Holdings
- 139,082(indirect: By Trust)
Common Stock
- 178,215(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
- [F2]Includes (i) remaining 83,334 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments on 9/17/15 and 9/17/16, and (ii) 56,700 previously reported shares issued as RSUs under the Plan that vest in four equal annual installments beginning on 2/27/15, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan.